Animal health professionals

  • Email
  • Help

Information for you

On this page, you will find information on the Agency’s activities, including news and events, that are most relevant to Animal health professionals and users of veterinary medicines such as pet owners.

You can contribute to the Agency’s work by responding to public consultations

Learn more about the European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) and its role regarding medicines for veterinary use.

Featured information

  • veterinary data requirements

    Consultation on revised guidelines on data requirements for minor use, minor species (MUMS)/limited market

    The revision updates the guidance in line with the experience gained over the last 10 years in setting appropriate data requirements for the quality, safety and efficacy for pharmaceutical products, and separately for immunologicals. The consultation runs for six months from January 2016.

  • Veterinary medicines highlights 2015

    EMA has released an overview of its key recommendations in 2015 on the authorisation of new veterinary medicines and the safety monitoring of authorised medicines. EMA recommended 14 veterinary medicines for marketing authorisation, half of which contain a new active substance.

  • Vaccines against epizootic diseases

    The EMA Management Board agreed financial incentives to support the availability of veterinary vaccines against certain epizootic diseases, such as bluetongue and foot and mouth disease, by waiving maintenance fees in the absence of sales and when specified criteria are met. See page 43 of the explanatory note on fees payable to the Agency. This initiative supports the principle of “prevention is better than cure” outlined in the European Commission’s Animal Health Strategy (2007-2013).

  • Finding Maximum Residue Limits (MRLs)

    A maximum residue limit (MRL) is the maximum acceptable concentration of an active substance that may be found in a food product obtained from an animal that has received a veterinary medicine. You can search or browse by substance for information on specific MRLs.

  • Antimicrobial resistance

    The Agency works with its partners to raise awareness of antimicrobial resistance in the European Union.

News for animal health professionals

Events of interest

  • 31/01/2017

    EMA

    Stakeholder focus group meeting on availability of lumpy skin disease (LSD) vaccines authorised to European Union (EU) standards

    The purpose of the meeting is to review the current scientific knowledge and regulatory environment for the development of LSD vaccines following incursion of the disease in 2015 and to identify regulatory options to facilitate the development and authorisation of vaccines in accordance with EU standards. The focus group meeting is within the scope of the Heads of Medicines Agencies Network Strategy on availability for veterinary vaccines that aims to increase their availability by ensuring efficient and effective cooperation between all stakeholders. ... Read more

  • 16/03/2017 - 17/03/2017

    CVMP

    European Medicines Agency veterinary medicines info day

    The European Medicines Agency veterinary medicines info day, organised in collaboration with International Federation for Animal Health Europe (IFAH-Europe), provides first-hand information on the latest developments in the scientific review, regulation and marketing authorisation procedure in the field of veterinary medicine regulation. For the first time, this year, European Medicines Agency (EMA) will have dedicated information points on esubmissions, veterinary application submissions and veterinary medicines innovation. ... Read more

  • 13/06/2016

    CVMP

    Veterinary focus group meeting with stakeholders: revision of the reflection paper on anthelmintic resistance

    The focus group meeting aims to facilitate the exchange of views from regulators, industry, research and veterinarians as part of the public consultation process on the revised draft reflection paper on anthelmintic resistance (CVMP/EWP/573536/2013-Rev.1). The Efficacy Working Party of the Committee for Medicinal Products for Veterinary Use (CVMP) revised the first version of the draft reflection paper to take into account comments received during public consultation. The CVMP adopted the revised reflection paper in April 2016 and released it for a second public consultation until 31 July 2016. ... Read more

  • 20/04/2016

    CVMP

    CVMP interested parties’ meeting

    The CVMP will be holding an interested parties meeting as part of regular stakeholder liaison. Topics for discussion this year will include MUMS and JEG 3R (replacement, reduction and refinement), availability of veterinary medicines antimicrobials resistance and discussion on operational excellence. ... Read more

  • 17/03/2016 - 18/03/2016

    CVMP

    European Medicines Agency/International Federation for Animal Health Europe info day 2016

    The info day covers the latest developments in the scientific review, regulation and marketing authorisation procedure. It is an opportunity for professionals to get first-hand information on current developments in the veterinary regulatory scene. Registration open. ... Read more

  • See all Events of interest

Information for:

Find information for...

Antimicrobial resistance infographic